OtherNeuropharmacology
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception
Simon Akerman, Holger Kaube and Peter James Goadsby
Journal of Pharmacology and Experimental Therapeutics January 12, 2004, DOI: https://doi.org/10.1124/jpet.103.059808
Simon Akerman
Holger Kaube

This is a PDF-only article. The first page of the PDF of this article appears below.

In this issue
OtherNeuropharmacology
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception
Simon Akerman, Holger Kaube and Peter James Goadsby
Journal of Pharmacology and Experimental Therapeutics January 12, 2004, DOI: https://doi.org/10.1124/jpet.103.059808
OtherNeuropharmacology
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception
Simon Akerman, Holger Kaube and Peter James Goadsby
Journal of Pharmacology and Experimental Therapeutics January 12, 2004, DOI: https://doi.org/10.1124/jpet.103.059808